Clinical Research and Evidence While large-scale human trials are still limited, the body of research on BPC-157 peptide paints a compelling picture of its therapeutic potential, especially in conditions that mirror the challenges of chronic Lyme disease
The Right Way to Use GLP-1 Medications GLP-1s should be part of a bigger picture plan , not the entire plan: Whole, real foods Protein + muscle support Hormone optimization Education + sustainability Final Thought GLP-1 medications are powerful
Stick to 1,0003,000 mg/day as recommended
all administration guidance must come from the clinical trial protocol and IMP label
Get care developed by in-house experts with decades of clinical excellence
Steve Small: Yeah, and premarin is the brand name of that kind of product example